Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antibodies
    Book Section

    Scheinberg, D. A.; Rosenblat, T. L.; Jurcic, J. G.; Sgouros, G.; Junghans, R. P.
    In Chabner, B. A.; Longo, D. L. (Eds.) Cancer Chemotherapy and Biotherapy: Principles and Practice. 5th ed (2011)

    Fulltext@MSK | Save
  • A phase III, open-label, randomized comparison of AS1413 (amonafide L-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (ACCEDE)
    Meeting Abstract

    Stone, R. M.; Allen, S. L.; Pigneux, A.; Stuart, R. K.; Wetzler, M.; Rizzieri, D.; Erba, H. P.; Damon, L. E.; Jang, J. H.; Tallman, M. S.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Arsenic trioxide followed by autologous stem cell transplant for patients with relapsed APL
    Meeting Abstract

    Shepard, D. D.; Kohrt, H. E.; Rosenblat, T. L.; Jurcic, J. G.; Park, J. H.; Goldman, A.; Dalal, J. S.; Maslak, P. G.; Jakubowski, A. A.; Klimek, V.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • CPX-351 versus cytarabine (CYT) and daunorubicin (DNR) therapy in newly diagnosed AML patients age 60-75: Safety and efficacy in secondary AML (sAML)
    Meeting Abstract

    Lancet, J. E.; Cortes, J. E.; Kovacsovics, T.; Hogge, D.; Kolitz, J. E.; Tallman, M. S.; Chiarella, M.; Louie, A. C.; Feldman, E. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac-lintuzumab) (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Ryan, C.; Frattini, M. G.; Cicic, D.; Larson, S. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Cytomorphologic and clinical features of AML with translocation (8;16) mimicking APL
    Meeting Abstract

    Jhanwar, S.; Diab, A.; Zickl, L.; Manji, G. A.; Patel, J.; Abdel-Wahab, O. I.; Jurcic, J. G.; Maslak, P. G.; Steinherz, P. G.; Paietta, E.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Chronic myelomonocytic leukemia (CMML) associated with symptomatic pericardial effusion
    Meeting Abstract

    Ibrahim, M. I.; Maslak, P. G.; Heaney, M. L.; George, M. S.; Downey, R. J.; Tallman, M. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Decitabine for the treatment of acute myeloid leukemia (AML): Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Ganetsky, A.; Adel, N. G.; Frattini, M. G.; Maslak, P. G.; Heaney, M. L.; Jurcic, J. G.; Tallman, M. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors
    Meeting Abstract

    Beryozkina, A.; Nichols, G. L.; Reckner, M.; Vassilev, L. T.; Rueger, R.; Jukofsky, L.; Middleton, S.; Andreeff, M.; Padmanabhan, S.; Strair, R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save